TriSalus Life Sciences, Inc.
TLSIW- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $798.0K in total; no superinvestor holds it.
Other share classesTLSI
Q1 2026 vs. Q4 2025
How the institutions holding TriSalus Life Sciences, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 8 | 7 | −1 |
| Shares | 1.07M | 1.02M | −44.6K (−4.2%) |
| Value | $1.77M | $1.23M | −$537.3K (−30.4%) |
New holders (1)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rockefeller Capital Management L.P. | 50 | $60 | 0.00% |
Sold out (2)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Wolverine Asset Management LLC | 30,990 | $51.4K |
| Bank of America Corp | 1,009 | $1.68K |